| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |